Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly

Clinical trial NCT01013675 · COMPLETED

Trial details

NCT number: NCT01013675
Sponsor: Abbott Biologicals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Vaccines

Start date: 2009-11-01
Primary completion: 2011-04-01
Enrollment: 622

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.